Log In
BCIQ
Print this Print this
 

diclofenac (Pennsaid 2%) (MNK-395)

Also known as: Pennsaid Viscous Solution (formerly Pennsaid Gel)

  Manage Alerts
Collapse Summary General Information
Company Nuvo Pharmaceuticals Inc.
DescriptionTopical NSAID 2% gel formulation
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat osteoarthrits (OA) knee pain; Treat pain due to grade I or II ankle sprains
Regulatory Designation U.S. - Undisclosed Review (Treat osteoarthrits (OA) knee pain)
PartnerEndo International plc;
Horizon Pharma plc;
NovaMedica LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$45.0M

$45.0M

0


 Deals Details
Get a free BioCentury trial today